Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 10/20 | 0.74 |
| ▸ | PDE7B | Q9NP56 | 5/20 | 0.74 |
| ▸ | PDE8A | O60658 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL100678 | 1.00 | PDE7A (0.74) | PDE7APDE7BPDE8AMAPTCYP3A4 | |
| SCHEMBL100756 | 0.93 | PDE7A (0.74) | PDE7APDE7BPDE8AMAPTCYP3A4 | |
| SCHEMBL100681 | 0.92 | PDE7A (0.78) | PDE7APDE7BPDE8ACYP3A4CYP2D6 | |
| SCHEMBL100792 | 0.91 | PDE7A (0.75) | PDE7APDE7BPDE8AMAPTALDH1A1 | |
| SCHEMBL99946 | 0.90 | PDE7A (0.76) | PDE7APDE7BPDE8AMAPTCYP3A4 | |
| SCHEMBL100068 | 0.90 | PDE7A (0.80) | PDE7APDE7BPDE8APOLB | |
| SCHEMBL30837822 | 0.90 | PDE7A (0.80) | PDE7APDE7BPDE8AMAPTCYP3A4 | |
| SCHEMBL100744 | 0.90 | PDE7A (0.80) | PDE7APDE7BPDE8AMAPTCYP3A4 | |
| SCHEMBL100958 | 0.90 | PDE7A (0.73) | PDE7APDE7BPDE8ACYP3A4CYP2D6 | |
| SCHEMBL100689 | 0.89 | PDE7A (0.77) | PDE7APDE7BPDE8AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4572765-A1 | USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE | Mitodicure GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024038089-A1 | USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE | MITODICURE GMBH (DE) | 2024-02-22 | — | — | WO | disclosed |